Oxytocin provides protection against diabetic polyneuropathy in rats

References

• Charnogursky G , Lee H , Lopez N . Diabetic neuropathy. Handb Clin Neurol. 2014;120:773–785.10.1016/B978-0-7020-4087-0.00051-6
   PubMedGoogle Scholar
• Vinik AI , Nevoret ML , Casellini C , et al. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013;42:747–787.10.1016/j.ecl.2013.06.001
   PubMed Web of Science ®Google Scholar
• Vincent AM , Calabek B , Roberts L , et al. Biology of diabetic neuropathy. Handb Clin Neurol. 2013;115:591–606.10.1016/B978-0-444-52902-2.00034-5
   PubMedGoogle Scholar
• Matsumoto T , Ohashi Y , Yamada N , et al. Hyperglycemia as a major determinant of distal polyneuropathy independent of age and diabetes in patients with recently diagnosed diabetes. Diabetes Res Clin Pract. 1994;26:109–113.10.1016/0168-8227(94)90147-3
   PubMed Web of Science ®Google Scholar
• Hinder LM , Vincent AM , Burant CF , et al. Bioenergetics in diabetic neuropathy: what we need to know. J Peripher Nerv Syst. 2012;17:10–14.10.1111/jns.2012.17.issue-s2
   PubMed Web of Science ®Google Scholar
• Kumar A , Negi G , Sharma SS . Neuroprotection by resveratrol in diabetic neuropathy: concepts & mechanisms. Curr Med Chem. 2013;20:4640–4645.10.2174/09298673113209990151
   PubMed Web of Science ®Google Scholar
• Ahmadvand H , Tavafi M , Khosrowbeygi A . Amelioration of altered antioxidant enzymes activity and glomerulosclerosis by coenzyme Q10 in alloxan-induced diabetic rats. J Diabetes Comp. 2012;26:476–482.10.1016/j.jdiacomp.2012.06.004
   PubMed Web of Science ®Google Scholar
• Várkonyi T , Putz Z , Keresztes K , et al. Current options and perspectives in the treatment of diabetic neuropathy. Curr Pharm Des. 2013;19:4981–5007.10.2174/13816128113199990310
   PubMed Web of Science ®Google Scholar
• Gimpl G , Fahrenholz F . The oxytocin receptor system: structure, function, and regulation. Physio Rev. 2011;81:630–68.
   Google Scholar
• Gutkowska J , Jankowski M . Oxytocin: old hormone, new drug. Pharmaceuticals. 2009;2:168–183.10.3390/ph203168
   Google Scholar
• Petersson M , Wiberg U , Lundeberg T , et al. Oxytocin decreases carrageenan induced inflammation in rats. Peptides. 2001;22:1479–1484.10.1016/S0196-9781(01)00469-7
   PubMed Web of Science ®Google Scholar
• Erbaş O , Oltulu F , Taskiran D . Amelioration of rotenone-induced dopaminergic cell death in the striatum by oxytocin treatment. Peptides. 2012;38:312–317.10.1016/j.peptides.2012.05.026
   PubMed Web of Science ®Google Scholar
• Erbaş O , Ergenoglu AM , Akdemir A , et al. Comparison of melatonin and oxytocin in the prevention of critical illness polyneuropathy in rats with experimentally induced sepsis. J Surg Res. 2013;183:313–320.10.1016/j.jss.2012.11.043
   PubMed Web of Science ®Google Scholar
• Erkanli Senturk G , Erkanli K , Aydin U , et al. The protective effect of oxytocin on ischemia/reperfusion injury in rat urinary bladder. Peptides. 2013;40:82–88.10.1016/j.peptides.2012.12.006
   PubMed Web of Science ®Google Scholar
• Akdemir A , Erbas O , Gode F , et al. Protective effect of oxytocin on ovarian ischemia-reperfusion injury in rats. Peptides. 2014;55:126–130.10.1016/j.peptides.2014.02.015
   PubMed Web of Science ®Google Scholar
• Rivlin AS , Tator CH . Objective clinical assessment of motor function after experimental spinal cord injury in the rat. J Neurosurg. 1977;47:577–581.10.3171/jns.1977.47.4.0577
   PubMed Web of Science ®Google Scholar
• Demougeot C , Marie C , Beley A . Importance of iron location in iron-induced hydroxyl radical production by brain slices. Life Sci. 2000;67:399–410.10.1016/S0024-3205(00)00638-X
   PubMed Web of Science ®Google Scholar
• Ellman GL . Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82:70–77.10.1016/0003-9861(59)90090-6
   PubMed Web of Science ®Google Scholar
• Tuck RR , Schmelzer JD , Low PA . Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain. 1984;107:935–950.10.1093/brain/107.3.935
   PubMed Web of Science ®Google Scholar
• Cotter MA , Love A , Watt MJ , et al. Effects of natural free radical scavengers on peripheral nerve and neurovascular function in diabetic rats. Diabetologia. 1995;38:1285–1294.10.1007/BF00401760
   PubMed Web of Science ®Google Scholar
• Chopra JS , Sawhney BB , Chakravorty RN . Pathology and time relationship of peripheral nerve changes in experimental diabetes. Neurol Sci. 1977;32:53–67.10.1016/0022-510X(77)90039-9
   Web of Science ®Google Scholar
• Thomas PK , Lascelles RG . The pathology of diabetic neuropathy. Q J Med. 1966;35:489–509.
   Google Scholar
• Yasuda H , Terada M , Maeda K , et al. Diabetic neuropathy and nerve regeneration. Prog Neurobiol. 2003;69:229–285.10.1016/S0301-0082(03)00034-0
   PubMed Web of Science ®Google Scholar
• Andriambeloson E , Baillet C , Vitte PA , et al. Interleukin-6 attenuates the development of experimental diabetes-related neuropathy. Neuropathology. 2006;26:32–42.10.1111/neu.2006.26.issue-1
   PubMed Web of Science ®Google Scholar
• Johnsen B , Fuglsang-Frederiksen A . Electrodiagnosis of polyneuropathy. Neurophysiol Clin. 2000;30:339–351.10.1016/S0987-7053(00)00237-9
   PubMed Web of Science ®Google Scholar
• Dey I , Midha N , Singh G , et al. Diabetic Schwann cells suffer from nerve growth factor and neurotrophin-3 underproduction and poor associability with axons. Glia. 2013;61:1990–1999.10.1002/glia.22570
   PubMed Web of Science ®Google Scholar
• Motawi TK , Rizk SM , Ibrahim IA , et al. Alterations in circulating angiogenic and anti-angiogenic factors in type 2 diabetic patients with neuropathy. Cell Biochem Funct. 2014;32:155–163.10.1002/cbf.v32.2
   PubMed Web of Science ®Google Scholar
• Pradhan Nabzdyk L , Kuchibhotla S , Guthrie P , et al. Expression of neuropeptides and cytokines in a rabbit model of diabetic neuroischemic wound healing. J Vasc Surg. 2013;58:766–775.
   PubMed Web of Science ®Google Scholar
• Tiaka EK , Papanas N , Manolakis AC , et al. The role of nerve growth factor in the prophylaxis and treatment of diabetic foot ulcers. Int J Burns Trauma. 2011;1:68–76.
   PubMedGoogle Scholar
• Tosaki T , Kamiya H , Yasuda Y , et al. Reduced NGF secretion by Schwann cells under the high glucose condition decreases neurite outgrowth of DRG neurons. Exp Neurol. 2008;213:381–387.10.1016/j.expneurol.2008.06.017
   PubMed Web of Science ®Google Scholar
• Anderson EJ , Rodriguez E , Anderson CA , et al. Increased propensity for cell death in diabetic human heart is mediated by mitochondrial-dependent pathways. Am J Physiol Heart Circ Physiol. 2011;300:H118–H124.10.1152/ajpheart.00932.2010
   PubMed Web of Science ®Google Scholar
• Sandireddy R , Yerra VG , Areti A , et al. Neuroinflammation and oxidative stress in diabetic neuropathy: futuristic strategies based on these targets. Int J Endocrinol. 2014;2014:674987.
   PubMed Web of Science ®Google Scholar
• Lavrik IN , Golks A , Krammer PH . Caspases: pharmacological manipulation of cell death. J Clin Invest. 2005;115:2265–72.
   Web of Science ®Google Scholar
• Vincent AM , Russell JW , Low P , et al. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev. 2004;25:612–628.10.1210/er.2003-0019
   PubMed Web of Science ®Google Scholar
• Ribas V , García-Ruiz C , Fernández-Checa JC . Glutathione and mitochondria. Front Pharmacol. 2014;5:151.
   PubMed Web of Science ®Google Scholar
• Wu G , Fang YZ , Yang S , et al. Glutathione metabolism and its implications for health. J Nutr. 2004;134:489–92.
   PubMed Web of Science ®Google Scholar
• Düşünceli F , Iseri SO , Ercan F , et al. Oxytocin alleviates hepatic ischemia-reperfusion injury in rats. Peptides. 2008;29:1216–1222.10.1016/j.peptides.2008.02.010
   PubMed Web of Science ®Google Scholar
• Houshmand F , Faghihi M , Zahediasl S . Biphasic protective effect of oxytocin on cardiac ischemia/reperfusion injury in anaesthetized rats. Peptides. 2009;30:2301–2308.10.1016/j.peptides.2009.09.010
   PubMed Web of Science ®Google Scholar
• İşeri SO , Şener G , Sağlam B , et al. Oxytocin ameliorates oxidative colonic inflammation by a neutrophil-dependent mechanism. Peptides. 2005;26:483–491.10.1016/j.peptides.2004.10.005
   PubMed Web of Science ®Google Scholar